共 50 条
- [1] Avelumab Maintenance Treatment After First-line Chemotherapy in Advanced Urothelial Carcinoma-A Cost-Effectiveness AnalysisCLINICAL GENITOURINARY CANCER, 2022, 21 (01) : 8 - 15Lin, DongLuo, ShaohongLin, ShenZhong, LixianZhou, WeiGu, DianHuang, XiaotingChen, QixinXu, XiongweiWeng, Xiuhua
- [2] Avelumab First-Line Maintenance Therapy: Managing Patients With Advanced Urothelial CarcinomaCLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (01) : 71 - 80Lapuente, MariaConway, DawnWood, Laura S.Kehoe, KiranBullock, Andrea CarrollDevgan, GeetaBurns, Kathleen D.
- [3] Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before MaintenanceEUROPEAN UROLOGY, 2024, 85 (02) : 154 - 163Sridhar, Srikala S.Powles, ThomasDuran, Miguel A. ClimentPark, Se HoonMassari, FrancescoThiery-Vuillemin, AntoineValderrama, Begona P.Ullen, AndersTsuchiya, NorihikoAragon-Ching, Jeanny B.Gupta, ShilpaPetrylak, Daniel P.Bellmunt, JoaquimWang, JingLaliberte, Robert J.di Pietro, AlessandraCosta, NunoGrivas, PetrosSternberg, Cora N.Loriot, Yohann
- [4] Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II studyESMO OPEN, 2024, 9 (09)Rodriguez-Vida, A.Valderrama, B. P.Castellano, D.Pinto, A.Mellado, B.Puente, J.Climent, M. A.Domenech, M.Vazquez, F.Perez-Gracia, J. L.Bonfill, T.Morales-Barrera, R.Gonzalez-Billalabeitia, E.Garcia-del-Muro, X.Maroto, P.Navarro-Gorro, N.Juanpere, N.Juan, O.Bellmunt, J.
- [5] Gemcitabine maintenance versus observation after first-line chemotherapy in patients with metastatic urothelial carcinoma: a retrospective studyTRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (05) : 2113 - 2121Kim, HyunhoLee, Seung-HwanKim, Dong HwanLee, Ji YoulHong, Sung-HooHa, U-SynKim, In-Ho
- [6] AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA: LONG-TERM OUTCOMES FROM JAVELIN BLADDER 100 IN SUBGROUPS DEFINED BY FIRST-LINE CHEMOTHERAPY REGIMEN AND ANALYSIS OF OVERALL SURVIVAL FROM START OF FIRST-LINE CHEMOTHERAPYJOURNAL OF UROLOGY, 2024, 211 (05): : E806 - E807Sridhar, Srikala S.Powles, ThomasGupta, ShilpaCliment Duran, Miguel A.Aragon-Ching, Jeanny B.Sternberg, Cora N.Cislo, PaulCosta, NunoSalvo, Portodi Pietro, AlessandraBellmunt, JoaquimGrivas, Petros
- [7] Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial CarcinomaADVANCES IN THERAPY, 2023, 40 (10) : 4134 - 4150Mansinho, AndreCruz, AndreiaMarconi, LorenzoPinto, CidaliaAugusto, Isabel
- [8] Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial CarcinomaAdvances in Therapy, 2023, 40 : 4134 - 4150André MansinhoAndreia CruzLorenzo MarconiCidália PintoIsabel Augusto
- [9] Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based ChemotherapyANTICANCER RESEARCH, 2024, 44 (03) : 1271 - 1279Shindo, TetsuyaHashimoto, KoheiTakahashi, AtsushiMiyamoto, ShintaroKunishima, YasuharuSato, ShunsukeFukuta, FumimasaHiyama, YoshikiTakayanagi, AkioKato, RyuichiWanifuchi, AtsushiUeki, YoheiOkada, ManabuAdachi, HidekiKobayashi, KoTanaka, ToshiakiMasumori, Naoya
- [10] Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter studyJAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (03) : 253 - 262Miyake, MakitoShimizu, TakutoOda, YukiTachibana, AkiraOhmori, ChihiroItami, YoshitakaKiba, KeisukeTomioka, AtsushiYamamoto, HiroakiOhnishi, KentaNishimura, NobutakaHori, ShuntaMorizawa, YosukeGotoh, DaisukeNakai, YasushiTorimoto, KazumasaFujii, TomomiTanaka, NobumichiFujimoto, Kiyohide